Selected research
Market Structure
Global Mebendazole API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Mebendazole API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Mebendazole API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Mebendazole API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mebendazole API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Mebendazole API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Mebendazole API include Shaanxi Hanjiang Pharmaceutical Group Co., Ltd, Jiangsu Quality Horizons Pharmtech Co., Ltd., Fengchen Group Co.,Ltd, Sudarshan Pharma Industries Limited, Solara Active Pharma Sciences, Optimus Drugs Pvt Ltd, K.A.Malle, Eurosoft Pharma Private Limited and Enomark Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Mebendazole API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mebendazole API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mebendazole API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mebendazole API market size, projected growth trends, production technologies, key applications, and end-use industries.
Mebendazole API Segment by Company
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
Jiangsu Quality Horizons Pharmtech Co., Ltd.
Fengchen Group Co.,Ltd
Sudarshan Pharma Industries Limited
Solara Active Pharma Sciences
Optimus Drugs Pvt Ltd
K.A.Malle
Eurosoft Pharma Private Limited
Enomark Pharma
Dolphinpharma
Conscientia Industrial Co., Ltd
Cipla
Anant Pharmaceuticals
Mebendazole API Segment by Type
Purity≥99%
Purity<99%
Mebendazole API Segment by Application
Tablet
Solvent
Others
Mebendazole API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebendazole API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mebendazole API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebendazole API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Mebendazole API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mebendazole API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mebendazole API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Mebendazole API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Purity≥99%
- Purity<99%
Applications
- Tablet
- Solvent
- Others
Companies covered
- Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
- Jiangsu Quality Horizons Pharmtech Co., Ltd.
- Fengchen Group Co.,Ltd
- Sudarshan Pharma Industries Limited
- Solara Active Pharma Sciences
- Optimus Drugs Pvt Ltd
- K.A.Malle
- Eurosoft Pharma Private Limited
- Enomark Pharma
- Dolphinpharma
- Conscientia Industrial Co., Ltd
- Cipla
- Anant Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Mebendazole API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Mebendazole API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Mebendazole API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Mebendazole API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Mebendazole API Market Dynamics
- 2.1 Mebendazole API Industry Trends
- 2.2 Mebendazole API Industry Drivers
- 2.3 Mebendazole API Industry Opportunities and Challenges
- 2.4 Mebendazole API Industry Restraints
3 Mebendazole API Market by Manufacturers
- 3.1 Global Mebendazole API Revenue by Manufacturers (2021-2026)
- 3.2 Global Mebendazole API Sales by Manufacturers (2021-2026)
- 3.3 Global Mebendazole API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Mebendazole API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Mebendazole API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Mebendazole API Manufacturers, Product Type & Application
- 3.7 Global Mebendazole API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Mebendazole API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Mebendazole API Players Market Share by Revenue in 2025
- 3.8.3 2025 Mebendazole API Tier 1, Tier 2, and Tier 3
4 Mebendazole API Market by Type
- 4.1 Mebendazole API Type Introduction
- 4.1.1 Purity≥99%
- 4.1.2 Purity<99%
- 4.2 Global Mebendazole API Sales by Type
- 4.2.1 Global Mebendazole API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Mebendazole API Sales by Type (2021-2032)
- 4.2.3 Global Mebendazole API Sales Market Share by Type (2021-2032)
- 4.3 Global Mebendazole API Revenue by Type
- 4.3.1 Global Mebendazole API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Mebendazole API Revenue by Type (2021-2032)
- 4.3.3 Global Mebendazole API Revenue Market Share by Type (2021-2032)
5 Mebendazole API Market by Application
- 5.1 Mebendazole API Application Introduction
- 5.1.1 Tablet
- 5.1.2 Solvent
- 5.1.3 Others
- 5.2 Global Mebendazole API Sales by Application
- 5.2.1 Global Mebendazole API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Mebendazole API Sales by Application (2021-2032)
- 5.2.3 Global Mebendazole API Sales Market Share by Application (2021-2032)
- 5.3 Global Mebendazole API Revenue by Application
- 5.3.1 Global Mebendazole API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Mebendazole API Revenue by Application (2021-2032)
- 5.3.3 Global Mebendazole API Revenue Market Share by Application (2021-2032)
6 Global Mebendazole API Sales by Region
- 6.1 Global Mebendazole API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Mebendazole API Sales by Region (2021-2032)
- 6.2.1 Global Mebendazole API Sales by Region (2021-2026)
- 6.2.2 Global Mebendazole API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Mebendazole API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Mebendazole API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Mebendazole API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Mebendazole API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Mebendazole API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Mebendazole API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Mebendazole API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Mebendazole API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Mebendazole API Revenue by Region
- 7.1 Global Mebendazole API Revenue by Region
- 7.1.1 Global Mebendazole API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Mebendazole API Revenue by Region (2021-2026)
- 7.1.3 Global Mebendazole API Revenue by Region (2027-2032)
- 7.1.4 Global Mebendazole API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Mebendazole API Revenue (2021-2032)
- 7.2.2 North America Mebendazole API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Mebendazole API Revenue (2021-2032)
- 7.3.2 Europe Mebendazole API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Mebendazole API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Mebendazole API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Mebendazole API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Mebendazole API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd
- 8.1.1 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Company Information
- 8.1.2 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Business Overview
- 8.1.3 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Mebendazole API Product Portfolio
- 8.1.5 Shaanxi Hanjiang Pharmaceutical Group Co., Ltd Recent Developments
- 8.2 Jiangsu Quality Horizons Pharmtech Co., Ltd.
- 8.2.1 Jiangsu Quality Horizons Pharmtech Co., Ltd. Company Information
- 8.2.2 Jiangsu Quality Horizons Pharmtech Co., Ltd. Business Overview
- 8.2.3 Jiangsu Quality Horizons Pharmtech Co., Ltd. Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Jiangsu Quality Horizons Pharmtech Co., Ltd. Mebendazole API Product Portfolio
- 8.2.5 Jiangsu Quality Horizons Pharmtech Co., Ltd. Recent Developments
- 8.3 Fengchen Group Co.,Ltd
- 8.3.1 Fengchen Group Co.,Ltd Company Information
- 8.3.2 Fengchen Group Co.,Ltd Business Overview
- 8.3.3 Fengchen Group Co.,Ltd Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Fengchen Group Co.,Ltd Mebendazole API Product Portfolio
- 8.3.5 Fengchen Group Co.,Ltd Recent Developments
- 8.4 Sudarshan Pharma Industries Limited
- 8.4.1 Sudarshan Pharma Industries Limited Company Information
- 8.4.2 Sudarshan Pharma Industries Limited Business Overview
- 8.4.3 Sudarshan Pharma Industries Limited Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sudarshan Pharma Industries Limited Mebendazole API Product Portfolio
- 8.4.5 Sudarshan Pharma Industries Limited Recent Developments
- 8.5 Solara Active Pharma Sciences
- 8.5.1 Solara Active Pharma Sciences Company Information
- 8.5.2 Solara Active Pharma Sciences Business Overview
- 8.5.3 Solara Active Pharma Sciences Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Solara Active Pharma Sciences Mebendazole API Product Portfolio
- 8.5.5 Solara Active Pharma Sciences Recent Developments
- 8.6 Optimus Drugs Pvt Ltd
- 8.6.1 Optimus Drugs Pvt Ltd Company Information
- 8.6.2 Optimus Drugs Pvt Ltd Business Overview
- 8.6.3 Optimus Drugs Pvt Ltd Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Optimus Drugs Pvt Ltd Mebendazole API Product Portfolio
- 8.6.5 Optimus Drugs Pvt Ltd Recent Developments
- 8.7 K.A.Malle
- 8.7.1 K.A.Malle Company Information
- 8.7.2 K.A.Malle Business Overview
- 8.7.3 K.A.Malle Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 K.A.Malle Mebendazole API Product Portfolio
- 8.7.5 K.A.Malle Recent Developments
- 8.8 Eurosoft Pharma Private Limited
- 8.8.1 Eurosoft Pharma Private Limited Company Information
- 8.8.2 Eurosoft Pharma Private Limited Business Overview
- 8.8.3 Eurosoft Pharma Private Limited Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Eurosoft Pharma Private Limited Mebendazole API Product Portfolio
- 8.8.5 Eurosoft Pharma Private Limited Recent Developments
- 8.9 Enomark Pharma
- 8.9.1 Enomark Pharma Company Information
- 8.9.2 Enomark Pharma Business Overview
- 8.9.3 Enomark Pharma Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Enomark Pharma Mebendazole API Product Portfolio
- 8.9.5 Enomark Pharma Recent Developments
- 8.10 Dolphinpharma
- 8.10.1 Dolphinpharma Company Information
- 8.10.2 Dolphinpharma Business Overview
- 8.10.3 Dolphinpharma Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Dolphinpharma Mebendazole API Product Portfolio
- 8.10.5 Dolphinpharma Recent Developments
- 8.11 Conscientia Industrial Co., Ltd
- 8.11.1 Conscientia Industrial Co., Ltd Company Information
- 8.11.2 Conscientia Industrial Co., Ltd Business Overview
- 8.11.3 Conscientia Industrial Co., Ltd Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Conscientia Industrial Co., Ltd Mebendazole API Product Portfolio
- 8.11.5 Conscientia Industrial Co., Ltd Recent Developments
- 8.12 Cipla
- 8.12.1 Cipla Company Information
- 8.12.2 Cipla Business Overview
- 8.12.3 Cipla Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Cipla Mebendazole API Product Portfolio
- 8.12.5 Cipla Recent Developments
- 8.13 Anant Pharmaceuticals
- 8.13.1 Anant Pharmaceuticals Company Information
- 8.13.2 Anant Pharmaceuticals Business Overview
- 8.13.3 Anant Pharmaceuticals Mebendazole API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Anant Pharmaceuticals Mebendazole API Product Portfolio
- 8.13.5 Anant Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Mebendazole API Value Chain Analysis
- 9.1.1 Mebendazole API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Mebendazole API Production Mode & Process
- 9.2 Mebendazole API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Mebendazole API Distributors
- 9.2.3 Mebendazole API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst